Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott's TriCor Off-Label, Kickback Settlement Is Fraction of 2012 Agreement

Executive Summary

$25m settlement resolves allegations covering 2006-2008 period; Abbott inked $1.5bn settlement with government six years ago involving Depakote promotion. This is DOJ's fourth pharma deal of the year.

Advertisement

Related Content

Pfizer Forks Over $700,000 For Copayment Coupon Claims
AmerisourceBergen Settlement On Injectable Drug Repackaging Includes Forfeiture Of Exec Pay
Government Pharma Investigations Target Pricing, Opioids, Trade Practices
Pfizer Agrees To Oversight Of Charitable Assistance Programs In DOJ Settlement
Whistleblower: Abbott off-label TriCor scheme put patients at risk
The Era Of Billion Dollar Pharma Settlements
Abbott’s Depakote Off-Label Settlement With DoJ Includes Court Probation
Legal and Regulatory Round-up: TriCor Suit Settles, Seroquel Suits Are Tossed, FDA Opens New Post

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124158

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel